• 瀏覽: 32,774
  • 回覆: 294
  • 追帖: 1
+9
[隱藏]
  1. 團隊在今年3月分別在中大醫院、九龍灣體育館及威爾斯親王醫院的社區疫苗接種中心,招募逾700名,年齡介乎18至79歲接種兩劑新冠疫苗的市民,當中打科興和復必泰的各佔約一半。團隊在他們接種疫苗前及接種第二劑兩劑疫苗後,分別抽取10毫升血液,然後進行多項抗體測試,發現復必泰對於產生中和抗體對付病毒的水平,較科興顯著地高;而在接種復必泰的巿民中,有8成人接種兩劑疫苗半年後,有5成保護效能。而接種科興的只有16%達到相關效能。
  2. 團隊又發現,兩種疫苗均有效產生減低感染重症及死亡風險的T細胞,但當中科興產生T細胞效能較為顯著



唔怪得歐美死亡率不跌反升。科興產生T細胞效能較為顯著,香港豬家只講抗體誤導市民。
傳統性滅活疫苗始終最安全有效
新聞來源連結:
https://hd.stheadline.com/news/realtime/hk/2284980/即時-港聞-許樹昌團隊發現接種復必泰中和抗體較科興高

[ 本帖最後由 Henrywu18 於 2021-12-7 09:21 PM 編輯 ]



引用:
原帖由 Henrywu18 於 2021-12-7 08:00 PM 發表
團隊在今年3月分別在中大醫院、九龍灣體育館及威爾斯親王醫院的社區疫苗接種中心,招募逾700名,年齡介乎18至79歲接種兩劑新冠疫苗的市民,當中打科興和復必泰的各佔約一半。
團隊在他們接種疫苗前及接種第二劑兩劑疫苗後,分別抽取10毫升血液,然後進行多項抗體測試,發現復必泰對於產生中和抗體對付病毒的水平,較科興顯著地高;而在接種復必泰的巿民中,有8成人接種兩劑疫苗半年後,有5成保護效能。而接種科興的只 ...
my guess is that the antibodies is not useful against omicron (mu has far less mutation in the spike protein against omicron and mu has a 10 fold reduction from the antibodies already)



引用:
原帖由 Henrywu18 於 2021-12-7 08:00 PM 發表
團隊在今年3月分別在中大醫院、九龍灣體育館及威爾斯親王醫院的社區疫苗接種中心,招募逾700名,年齡介乎18至79歲接種兩劑新冠疫苗的市民,當中打科興和復必泰的各佔約一半。
團隊在他們接種疫苗前及接種第二劑兩劑疫苗後,分別抽取10毫升血液,然後進行多項抗體測試,發現復必泰對於產生中和抗體對付病毒的水平,較科興顯著地高;而在接種復必泰的巿民中,有8成人接種兩劑疫苗半年後,有5成保護效能。而接種科興的只 ...
同意
又是他們傻迫香港人,以為抗體高有用么



CB says there is no data on t cell now there is a study


[隱藏]



即係復必泰對付變種差過科興囉。


引用:
原帖由 pbd456 於 2021-12-7 08:12 PM 發表

my guess is that the antibodies is not useful against omicron (mu has far less mutation in the spike protein against omicron and mu has a 10 fold reduction from the antibodies already)
Antibodies for original spike protein can't bind the new variants.
The immune cells need to make new antibodies with minor modifications after the infection of new variants.
Inactivated virus provide more information for B/T cells and speed up the process.



引用:
原帖由 lovecpc 於 2021-12-7 08:13 PM 發表

同意
又是他們傻迫香港人,以為抗體高有用么
特首話抗體唔係越高越好,果班醫護豬家日日只識講抗體推銷西藥。
付統性滅活疫苗始終最安全有效



提示: 違規內容已被屏蔽
[隱藏]
引用:
原帖由 泛民之星陳盲刎 於 2021-12-7 08:32 PM 發表

Antibodies for original spike protein can't bind the new variants.
The immune cells need to make new antibodies with minor modifications after the infection of new variants.
Inactivated virus prov ...
I think they are still useful but not as effective. delta has spike protein mutation and it results in 4-6 fold reduction in usefulness against delta.

omicron has even more mutation, it could result in 30x fold reduction which means antibodies is quite useless itself in protection against infection.

HK had a case with 2 dose moderna for 38 years old with 2nd dose on Oct 4.  in theory, he would have very high antibodies as he was recently vaccinated with the vaccine that produces the most antibodies



unlike HKU,HKU can only use commercial kits to measure antibodies than high school students can do.


引用:
原帖由 Henrywu18 於 2021-12-7 08:00 PM 發表
團隊在今年3月分別在中大醫院、九龍灣體育館及威爾斯親王醫院的社區疫苗接種中心,招募逾700名,年齡介乎18至79歲接種兩劑新冠疫苗的市民,當中打科興和復必泰的各佔約一半。
團隊在他們接種疫苗前及接種第二劑兩劑疫苗後,分別抽取10毫升血液,然後進行多項抗體測試,發現復必泰對於產生中和抗體對付病毒的水平,較科興顯著地高;而在接種復必泰的巿民中,有8成人接種兩劑疫苗半年後,有5成保護效能。而接種科興的只 ...
傷港成班親老尾講毒磚家
未停過抬高伏必汰踩科興



即係科興好過伏必泰對抗新冠病毒啦


但當中科興產生T細胞效能較為顯著。



突破盲腸!


[隱藏]
引用:
原帖由 pbd456 於 2021-12-7 08:13 PM 發表
CB says there is no data on t cell now there is a study
一早估到科興T細胞掂, 果然係顯注比復必泰高, 沒選錯到.

不過妓者又玩標題, 無知市民又被誤導



提示:支持鍵盤翻頁左 右
[按此隱藏 Google 建議的相符內容]